Who
Michael A. Beindorff
Director
Company insider
Files Form 4 as: Director, Lifevantage; Director, Wpt Enterprises.
In numbers
- Trades disclosed
- 78
- Buys
- 19
- Sells
- 8
- Bought
- $437K
- Sold
- $746K
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 30 May 2007
- Last trade
- 3 Jun 2026
- Last filed
- 5 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 3 Jun 2026filed 5 Jun 2026 | LFVN LifevantageBiotechnology | SEC FORM 4 Sold | $85K10,000 at $8.55 | filing |
| 3 Jun 2026filed 5 Jun 2026 | LFVN LifevantageBiotechnology | SEC FORM 4 Sold | $86K10,000 at $8.55 | filing |
| 25 Nov 2025filed 17 Dec 2025 | LFVN LifevantageBiotechnology | SEC FORM 4 Code G | —7,819 at $0.00 | filing |
| 25 Nov 2025filed 17 Dec 2025 | LFVN LifevantageBiotechnology | SEC FORM 4 Code G | —7,819 at $0.00 | filing |
| 19 Nov 2025filed 21 Nov 2025 | LFVN LifevantageBiotechnology | SEC FORM 4 Sold | $81K12,607 at $6.42 | filing |
| 7 Nov 2025filed 10 Nov 2025 | LFVN LifevantageBiotechnology | SEC FORM 4 Sold | $7,3301,000 at $7.33 | filing |
| 7 Nov 2025filed 10 Nov 2025 | LFVN LifevantageBiotechnology | SEC FORM 4 Sold | $242K35,000 at $6.92 | filing |
| 6 Nov 2025filed 10 Nov 2025 | LFVN LifevantageBiotechnology | SEC FORM 4 Code A | $105K13,531 at $7.76 | filing |
| 9 Sep 2025filed 11 Sep 2025 | LFVN LifevantageBiotechnology | SEC FORM 4 Sold | $47K4,125 at $11.44 | filing |
| 9 Sep 2025filed 11 Sep 2025 | LFVN LifevantageBiotechnology | SEC FORM 4 Sold | $2,270200 at $11.35 | filing |
| 10 Feb 2025filed 12 Feb 2025 | LFVN LifevantageBiotechnology | SEC FORM 4 Sold | $114K5,850 at $19.54 | filing |
| 12 Dec 2024filed 7 Aug 2025 | LFVN LifevantageBiotechnology | SEC FORM 4 Code G | —17,185 at $0.00 | filing |
| 12 Dec 2024filed 7 Aug 2025 | LFVN LifevantageBiotechnology | SEC FORM 4 Code G | —17,185 at $0.00 | filing |
| 7 Nov 2024filed 12 Nov 2024 | LFVN LifevantageBiotechnology | SEC FORM 4 Code A | $105K7,819 at $13.43 | filing |
| 30 Nov 2023filed 29 Jul 2024 | LFVN LifevantageBiotechnology | SEC FORM 4 Code G | —19,430 at $0.00 | filing |
| 30 Nov 2023filed 29 Jul 2024 | LFVN LifevantageBiotechnology | SEC FORM 4 Code G | —19,430 at $0.00 | filing |
| 20 Nov 2023filed 22 Nov 2023 | LFVN LifevantageBiotechnology | SEC FORM 4 Sold | $33K5,500 at $6.00 | filing |
| 16 Nov 2023filed 20 Nov 2023 | LFVN LifevantageBiotechnology | SEC FORM 4 Code A | $105K17,185 at $6.11 | filing |
| 25 May 2023filed 26 May 2023 | LFVN LifevantageBiotechnology | SEC FORM 4 Bought | $8,4202,000 at $4.21 | filing |
| 24 May 2023filed 26 May 2023 | LFVN LifevantageBiotechnology | SEC FORM 4 Bought | $13K3,000 at $4.40 | filing |
News
LifeVantage Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)LFVN · manilatimes.net · 12 Oct 2026
0 headlines in the last 90 days name Michael A. Beindorff; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.